Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT00120419
What this trial is testing

Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)

Who this might be right for
HIV Infection
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 90
Early research (Phase 1)Study completedNCT00129194
What this trial is testing

Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens

Who this might be right for
HIV Infections
Koronis Pharmaceuticals. 40
Not applicableStudy completedNCT00009256
What this trial is testing

Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 65
Not applicableStudy completedNCT03187964
What this trial is testing

Xpert Ultra and Xpert HIV-VL in People Living With HIV

Who this might be right for
HIV/AIDSTB - TuberculosisAntiretroviral Therapy, Highly Active
University of Stellenbosch 1,053
Not applicableStudy completedNCT02109887
What this trial is testing

Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP)

Who this might be right for
Non-HIV Patients With Pneumocystis Jiroveci Pneumonia
Asan Medical Center 76
Not applicableStudy completedNCT00002375
What this trial is testing

Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 24
Testing effectiveness (Phase 2)Study completedNCT00959699
What this trial is testing

A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)

Who this might be right for
HIV InfectionsHepatitis CHCV Infection
Merck Sharp & Dohme LLC 99
Not applicableStudy completedNCT00000693
What this trial is testing

Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Large-scale testing (Phase 3)Study completedNCT01709084
What this trial is testing

A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Who this might be right for
Human Immunodeficiency Virus-type 1 Infection
Janssen-Cilag International NV 426
Post-approval studies (Phase 4)UnknownNCT04993872
What this trial is testing

Pharmacokinetics of Calcineurin & mTOR Inhibitors in HIV-1 Infected Kidney Transplant Recipients After Switch to BIC/FTC/TAF

Who this might be right for
HIV-infected Patient Kidney Transplant Recipient
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 5
Not applicableStudy completedNCT02167100
What this trial is testing

Patient Retention in HIV Medical Care in a Primary Care Practice in Australia

Who this might be right for
HIV
Holdsworth House Medical Practice 1,537
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Not applicableStudy completedNCT04973254
What this trial is testing

Improving Treatment and Retention Adherence in Nontraditional Settings

Who this might be right for
HIV Infections
Boston Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT01199939
What this trial is testing

The Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients

Who this might be right for
Human Immunodeficiency Virus (HIV)
Tibotec, Inc 54
Post-approval studies (Phase 4)Study completedNCT00287677
What this trial is testing

Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 33
Not applicableEnded earlyNCT01567722
What this trial is testing

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Who this might be right for
Lung CancerLymphoma
AIDS Malignancy Consortium 114
Testing effectiveness (Phase 2)Study completedNCT04059770
What this trial is testing

Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients

Who this might be right for
HistoplasmosisAIDS
Alessandro Pasqualotto 118
Large-scale testing (Phase 3)Study completedNCT01924286
What this trial is testing

Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone

Who this might be right for
Immune Reconstitution Inflammatory SyndromeHIVTuberculosis
University of Cape Town 240
Not applicableUnknownNCT02054494
What this trial is testing

T1 Mapping in HIV Patients With High and Low CD4+ Cell Counts

Who this might be right for
Heart DiseasesHIV
University Hospital, Bonn 100
Large-scale testing (Phase 3)Study completedNCT03913195
What this trial is testing

Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection

Who this might be right for
HIV-1-infection
TaiMed Biologics Inc. 43
Next Page